ARCHIVES

High-Dose Vitamin D With Docetaxel In Testing For Advanced Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 25 No. 9 | September 27, 2002

Download PDF Visit The Full Archive

Related Articles

CMS Considering Regulatory Standards for Drug Company Bundling of Products.

October 20, 2006

Memorial’s Scher Warns FDA About Flaws In Provenge Data, Urges Not To Approve.

April 13, 2007

Prime Contract Subcontract Opportunities

January 24, 1975

FASEB Says NIH Budge Should Reach $10 Bil. In Fiscal 1993

January 10, 1992

NCI’s Frei & Freireich era Lauded As Researchers Receive First NIH Distinguished Alumni Award

September 14, 1990

Cancer, AIDS Patient Advocates List Drug Development Concerns

May 12, 1989